carbamazepine has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 5 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We assessed the effects of oxcarbazepine treatment in 67 cases of cryoglobulinemia related neuropathy, who did not respond to either steroid or Gabapentin, or Pregabalin." | 7.88 | Hepatitis C-related cryoglobulinemic neuropathy: potential role of oxcarbazepine for pain control. ( Caruso, P; Dal Ben, M; Gazzin, S; Moretti, R; Tiribelli, C, 2018) |
| "SCY-635 is a novel nonimmunosuppressive cyclosporine-based analog that exhibits potent suppression of hepatitis C virus (HCV) replication in vitro." | 7.76 | SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro. ( Erdmann, F; Fischer, G; Harris, R; Hopkins, S; Huang, Z; Murray, MG; Ribeill, Y; Scorneaux, B; Smitley, C; Wring, S, 2010) |
| "We assessed the effects of oxcarbazepine treatment in 67 cases of cryoglobulinemia related neuropathy, who did not respond to either steroid or Gabapentin, or Pregabalin." | 3.88 | Hepatitis C-related cryoglobulinemic neuropathy: potential role of oxcarbazepine for pain control. ( Caruso, P; Dal Ben, M; Gazzin, S; Moretti, R; Tiribelli, C, 2018) |
| "SCY-635 is a novel nonimmunosuppressive cyclosporine-based analog that exhibits potent suppression of hepatitis C virus (HCV) replication in vitro." | 3.76 | SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro. ( Erdmann, F; Fischer, G; Harris, R; Hopkins, S; Huang, Z; Murray, MG; Ribeill, Y; Scorneaux, B; Smitley, C; Wring, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hopkins, S | 1 |
| Scorneaux, B | 1 |
| Huang, Z | 1 |
| Murray, MG | 1 |
| Wring, S | 1 |
| Smitley, C | 1 |
| Harris, R | 1 |
| Erdmann, F | 1 |
| Fischer, G | 1 |
| Ribeill, Y | 1 |
| Moretti, R | 1 |
| Caruso, P | 1 |
| Dal Ben, M | 1 |
| Gazzin, S | 1 |
| Tiribelli, C | 1 |
| Burger, DM | 1 |
| Arends, JE | 1 |
| Jacobs, BS | 1 |
| van Elst-Laurijsen, DH | 1 |
| de Kanter, CT | 1 |
| van Maarseveen, EM | 1 |
| Verwey-van Wissen, CP | 1 |
| Hoepelman, AI | 1 |
| Pamuk, ON | 1 |
| Cakir, N | 1 |
| Soy, M | 1 |
| Aktoz, M | 1 |
| Celik, Y | 1 |
| Akdemir, O | 1 |
| Vespignani, H | 1 |
| Roger, J | 1 |
1 review available for carbamazepine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Mitral valve vegetation and cerebral emboli in a primary antiphospholipid syndrome patient who had hepatitis C virus infection: report of a case and review of the literature.
Topics: Adult; Antibodies, Anticardiolipin; Anticoagulants; Anticonvulsants; Antiphospholipid Syndrome; Carb | 2003 |
4 other studies available for carbamazepine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro.
Topics: Animals; Antiviral Agents; Cell Line; Cells, Cultured; Cyclophilin A; Cyclosporins; Dogs; Dose-Respo | 2010 |
Hepatitis C-related cryoglobulinemic neuropathy: potential role of oxcarbazepine for pain control.
Topics: Analgesics; Carbamazepine; Cryoglobulinemia; Female; Hepatitis C; Humans; Male; Middle Aged; Neuralg | 2018 |
Managing drug-drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: a 'tour de force' for clinical pharmacologists.
Topics: Anticonvulsants; Antiviral Agents; Atazanavir Sulfate; Carbamazepine; Cytochrome P-450 CYP3A; Drug D | 2014 |
[Medico-legal aspects of temporal lobe epilepsy in prison].
Topics: Adult; Aggression; Anticonvulsants; Carbamazepine; Epilepsy, Temporal Lobe; Hallucinations; Health S | 2002 |